Rating History for Morphic Therapeutic (MORF) by RBC Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/9/2024 | Gregory Renza | Downgrade | Sector Perform (Outperform) |
57.00 (70.00) |
31.84 (56.99) |
78.99% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
